{
  "label": "clinical_signal_03_dx_renal_biomarker_study_029",
  "artifact_type": "distractor_episode",
  "artifact_id": "sha256:f5af335bf7de77285be82dbb895aac855a59fb9424ae5cca9d36c2abcd36d0ac",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:c334c83f0e5586d31926bcb6e60115e9bfeccda6fed885884ee61b742c0bfe26"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:58:16.796184",
  "content": "## 2024-09-16 Daily Operations Summary\n\n### Enrollment\n- Total Enrolled: 88\n- Active: 76\n- Screen Failures Cumulative: 64\n- Withdrawals Cumulative: 12\n\n### Enrollment By Cohort\n- 10mg: 21\n- 25mg: 21\n- 50mg: 23\n- 100mg: 23\n\n### Biomarkers By Cohort\n- 10mg\n  - KIM1 (ng/mL) Mean: 1.82\n  - KIM1 (ng/mL) SD: 0.36\n  - NGAL (ng/mL) Mean: 68.4\n  - NGAL (ng/mL) SD: 16.2\n  - CysC (mg/L) Mean: 0.84\n  - CysC (mg/L) SD: 0.13\n  - eGFR (mL/min) Mean: 62.2\n  - eGFR (mL/min) SD: 10.1\n  - UACR (mg/g) Mean: 34.9\n  - UACR (mg/g) SD: 27.1\n  - Serum Creatinine (mg/dL) Mean: 1.15\n  - Serum Creatinine (mg/dL) SD: 0.15\n  - Urine Protein (mg/dL) Mean: 17.3\n  - Urine Protein (mg/dL) SD: 3.1\n  - Urine Output (mL/24h) Mean: 1752\n  - Urine Output (mL/24h) SD: 389\n- 25mg\n  - KIM1 (ng/mL) Mean: 1.95\n  - KIM1 (ng/mL) SD: 0.42\n  - NGAL (ng/mL) Mean: 55.1\n  - NGAL (ng/mL) SD: 13.8\n  - CysC (mg/L) Mean: 0.77\n  - CysC (mg/L) SD: 0.13\n  - eGFR (mL/min) Mean: 64.4\n  - eGFR (mL/min) SD: 9.1\n  - UACR (mg/g) Mean: 82.9\n  - UACR (mg/g) SD: 15.5\n  - Serum Creatinine (mg/dL) Mean: 1.38\n  - Serum Creatinine (mg/dL) SD: 0.12\n  - Urine Protein (mg/dL) Mean: 15.9\n  - Urine Protein (mg/dL) SD: 5.8\n  - Urine Output (mL/24h) Mean: 1790\n  - Urine Output (mL/24h) SD: 344\n- 50mg\n  - KIM1 (ng/mL) Mean: 1.68\n  - KIM1 (ng/mL) SD: 0.55\n  - NGAL (ng/mL) Mean: 47.9\n  - NGAL (ng/mL) SD: 13.7\n  - CysC (mg/L) Mean: 0.90\n  - CysC (mg/L) SD: 0.12\n  - eGFR (mL/min) Mean: 71.6\n  - eGFR (mL/min) SD: 10.6\n  - UACR (mg/g) Mean: 98.5\n  - UACR (mg/g) SD: 34.8\n  - Serum Creatinine (mg/dL) Mean: 1.41\n  - Serum Creatinine (mg/dL) SD: 0.25\n  - Urine Protein (mg/dL) Mean: 41.8\n  - Urine Protein (mg/dL) SD: 5.5\n  - Urine Output (mL/24h) Mean: 1648\n  - Urine Output (mL/24h) SD: 356\n- 100mg\n  - KIM1 (ng/mL) Mean: 1.23\n  - KIM1 (ng/mL) SD: 0.46\n  - NGAL (ng/mL) Mean: 101.5\n  - NGAL (ng/mL) SD: 9.7\n  - CysC (mg/L) Mean: 1.18\n  - CysC (mg/L) SD: 0.11\n  - eGFR (mL/min) Mean: 56.9\n  - eGFR (mL/min) SD: 8.5\n  - UACR (mg/g) Mean: 122.5\n  - UACR (mg/g) SD: 20.3\n  - Serum Creatinine (mg/dL) Mean: 1.00\n  - Serum Creatinine (mg/dL) SD: 0.20\n  - Urine Protein (mg/dL) Mean: 34.3\n  - Urine Protein (mg/dL) SD: 7.0\n  - Urine Output (mL/24h) Mean: 1743\n  - Urine Output (mL/24h) SD: 330\n\n### Dose Response\n- KIM1 Dose Correlation (r): 0.414\n- NGAL Dose Correlation (r): 0.285\n- eGFR Dose Correlation (r): -0.155\n- UACR Dose Correlation (r): 0.221\n\n### Safety Labs\n- Hemoglobin (g/dL) Mean: 13.8\n- Hemoglobin (g/dL) SD: 1.0\n- Hematocrit (%) Mean: 39.6\n- Hematocrit (%) SD: 3.8\n- WBC (k/\u00b5L) Mean: 6.8\n- WBC (k/\u00b5L) SD: 1.1\n- Platelets (k/\u00b5L) Mean: 243\n- Platelets (k/\u00b5L) SD: 43\n- Sodium (mEq/L) Mean: 139.0\n- Sodium (mEq/L) SD: 2.6\n- Potassium (mEq/L) Mean: 4.2\n- Potassium (mEq/L) SD: 0.4\n- Bicarbonate (mEq/L) Mean: 25.5\n- Bicarbonate (mEq/L) SD: 1.5\n- Phosphorus (mg/dL) Mean: 4.1\n- Phosphorus (mg/dL) SD: 0.6\n\n### Adverse Events\n- AE ID: RB-AE-2904, Description: dizziness, Grade: 1, Relatedness: unlikely related, Resolved: true, Cohort: 100mg\n- AE ID: RB-AE-2951, Description: nausea, Grade: 1, Relatedness: unlikely related, Resolved: true, Cohort: 100mg\n- AE ID: RB-AE-2984, Description: dizziness, Grade: 1, Relatedness: unlikely related, Resolved: true, Cohort: 100mg\n\n### Protocol Deviations\n- None\n\n### Events\n- DSMB safety data snapshot prepared\n- Cohort 50mg enrollment status reviewed at sponsor call\n\n### Notes\n- Week 29: Renal biomarker collection on schedule. 88 subjects enrolled across 4 cohorts. eGFR and urinary biomarkers within expected variability.",
  "metadata": {
    "episode_type": "distractor",
    "theme": "renal_biomarker_study",
    "theme_index": 0,
    "local_index": 29,
    "scope_id": "clinical_signal_03",
    "layer_name": "distractor_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "b39286bd69ab4fc400a914137914eaa7bda71068fc11fdf31fc1054c8fc775f5",
      "components": {
        "transform": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
        "inputs": "e1e99cb871eaf7b9"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "a88665a5359d5ac5d2c858c77a2a19318c209adeea6fae2b838d79e11f6aba2b",
      "components": {
        "transform_id": "01137a4997b78f86",
        "source": "c42d9c6282d5331f",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}